S. K. TOPRAK Et Al. , "Multiple Myeloma Patients Who Are Chemosensitive and Present with Plasma Cells Lacking Phosphorylated Retinoblastoma and/or Cyclin A Expression Benefit From High Dose Therapy and Autologous Stem Cell Transplantation More," 52nd Annual Meeting of the American-Society-of-Hematology (ASH) , vol.116, Florida, United States Of America, pp.577, 2010
TOPRAK, S. K. Et Al. 2010. Multiple Myeloma Patients Who Are Chemosensitive and Present with Plasma Cells Lacking Phosphorylated Retinoblastoma and/or Cyclin A Expression Benefit From High Dose Therapy and Autologous Stem Cell Transplantation More. 52nd Annual Meeting of the American-Society-of-Hematology (ASH) , (Florida, United States Of America), 577.
TOPRAK, S. K., Kaygusuz, G., Kursun, N., Ozu, D., Cakar, M. K., KUZU, I., ... BEKSAÇ, M.(2010). Multiple Myeloma Patients Who Are Chemosensitive and Present with Plasma Cells Lacking Phosphorylated Retinoblastoma and/or Cyclin A Expression Benefit From High Dose Therapy and Autologous Stem Cell Transplantation More . 52nd Annual Meeting of the American-Society-of-Hematology (ASH) (pp.577). Florida, United States Of America
TOPRAK, SELAMİ Et Al. "Multiple Myeloma Patients Who Are Chemosensitive and Present with Plasma Cells Lacking Phosphorylated Retinoblastoma and/or Cyclin A Expression Benefit From High Dose Therapy and Autologous Stem Cell Transplantation More," 52nd Annual Meeting of the American-Society-of-Hematology (ASH), Florida, United States Of America, 2010
TOPRAK, SELAMİ K. Et Al. "Multiple Myeloma Patients Who Are Chemosensitive and Present with Plasma Cells Lacking Phosphorylated Retinoblastoma and/or Cyclin A Expression Benefit From High Dose Therapy and Autologous Stem Cell Transplantation More." 52nd Annual Meeting of the American-Society-of-Hematology (ASH) , Florida, United States Of America, pp.577, 2010
TOPRAK, S. K. Et Al. (2010) . "Multiple Myeloma Patients Who Are Chemosensitive and Present with Plasma Cells Lacking Phosphorylated Retinoblastoma and/or Cyclin A Expression Benefit From High Dose Therapy and Autologous Stem Cell Transplantation More." 52nd Annual Meeting of the American-Society-of-Hematology (ASH) , Florida, United States Of America, p.577.
@conferencepaper{conferencepaper, author={SELAMİ KOÇAK TOPRAK Et Al. }, title={Multiple Myeloma Patients Who Are Chemosensitive and Present with Plasma Cells Lacking Phosphorylated Retinoblastoma and/or Cyclin A Expression Benefit From High Dose Therapy and Autologous Stem Cell Transplantation More}, congress name={52nd Annual Meeting of the American-Society-of-Hematology (ASH)}, city={Florida}, country={United States Of America}, year={2010}, pages={577} }